Patents by Inventor Wendy L. Metz

Wendy L. Metz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220016272
    Abstract: A method of diagnosing a CD206 expressing cell-related disorder by administering a pharmaceutical composition to a subject, the composition including a carrier molecule having a detectable moiety attached thereto. The carrier molecule has a dextran backbone, and at least one receptor substrate conjugated, directly or indirectly, to the dextran backbone, wherein the receptor substrate is chosen so as to specifically bind to CD206. A method of treating a CD206 expressing cell-related disorder is also provided, as well as an ex vivo method and kit for quantitating the number of cells expressing CD206 in a bodily fluid.
    Type: Application
    Filed: February 19, 2021
    Publication date: January 20, 2022
    Inventors: Frederick O. COPE, Michael S. BLUE, Wendy L. METZ, Larry S. SCHLESINGER
  • Publication number: 20150023876
    Abstract: A method of diagnosing a CD206 expressing cell-related disorder by administering a pharmaceutical composition to a subject, the composition including a carrier molecule having a detectable moiety attached thereto. The carrier molecule has a dextran backbone, and at least one receptor substrate conjugated, directly or indirectly, to the dextran backbone, wherein the receptor substrate is chosen so as to specifically bind to CD206. A method of treating a CD206 expressing cell-related disorder is also provided, as well as an ex vivo method and kit for quantitating the number of cells expressing CD206 in a bodily fluid.
    Type: Application
    Filed: July 22, 2014
    Publication date: January 22, 2015
    Inventors: Frederick O. Cope, Michael S. Blue, Wendy L. Metz, Larry S. Schlesinger